Trending...
- AI Visibility: The Key to Beating Google's AI Overviews and Regaining Traffic
- New Mobile Car Detailing Platform Connects Drivers with On-Demand Local Pros
- Cal State LA secures funding for two artificial intelligence projects from CSU
The Board of Directors of Sedia Biosciences Corporation today announced a series of changes to the Company's executive management team.
BEAVERTON, Ore. - Californer -- Roger I. Gale, previously Chief Executive Officer and Chairman of the Board of Directors, was appointed Executive Chairman of Sedia. Mr. Gale is a co-founder of Sedia. Dr. Lynn Stevenson, Member of the Board of Directors said "Mr. Gale has been instrumental in the Company's evolution and growth. His international experience as an executive for both large and small corporations has brought a unique perspective and played a critical role in its success. Mr. Gale will continue to drive for growth with an ever-present entrepreneurial mindset in his new role as Executive Chairman."
Ronald W. Mink, Ph.D., was appointed Chief Executive Officer. Dr. Mink was previously President and Chief Science Officer. He was reappointed President and will also serve as interim Chief Science Officer. Dr. Mink is a co-founder of Sedia. Roger Gale said "In his previous roles as President and Chief Science Officer, Dr. Mink made outstanding contributions to the growth and scale-up of Sedia's premier HIV products, while simultaneously leading research and development efforts toward novel product lines. His leadership skills, depth of scientific knowledge and passion for innovation will serve the Company well in his new role as Chief Executive Officer."
More on The Californer
Nancy Lime, previously Senior Vice President, Operations, was appointed Chief Operating Officer. Dr. Mink said "In her previous role as Senior Vice President, Operations, Ms. Lime has had a major impact on the performance of the Company. Over the past two years she has helped drive growth in production capacity, sales revenue and profitability and made a significant contribution to improvements in our quality systems. In 2020, she also led the design, build-out and relocation of the Company to our new assay development and manufacturing facility. Ms. Lime's experience, leadership and drive will serve the Company well in her new role as Chief Operating Officer."
Clay Roscoe, MD, MSc, previously Medical Advisor to the Company, was appointed Chief Medical Officer. Dr. Mink said "Dr. Roscoe brings to the Company years of clinical practice in HIV medicine and experience with the U.S. Centers for Disease Control (CDC) in Namibia, Southern Africa. Dr. Roscoe's field experience working first-hand with patients and leading national diagnostic assay programs for both HIV and TB will provide invaluable knowledge and insight for new product development and market analysis. We are pleased to welcome Dr. Roscoe to the team."
Jason Boone, Ph.D., was appointed President of Floragenex, a wholly owned subsidiary of Sedia. Dr. Boone will continue to serve as Sedia's Vice President of Sales and Marketing. Dr. Mink said "Dr. Boone began with Floragenex in 2009 and has continued to implement processes to facilitate growth for the Company. With a keen business acumen, scientific expertise, and enthusiasm in growing start-up companies, we are pleased to have Dr. Boone driving our Sales and Marketing program and serving in the role of President of Floragenex."
More on The Californer
About Sedia Biosciences Corporation
Sedia Biosciences is a privately held medical device and diagnostics company founded in 2009 and is based in Beaverton, Oregon, USA. Our goal is to become a leader in three areas intended to advance global access to care: (1) state-of-the-art rapid point-of-care diagnostic assays, (2) novel epidemiological disease surveillance assays and other Public Health tools and (3) innovative clinical specimen collection devices to improve and facilitate remote collection of specimens for follow-up testing. Sedia brings together a dedicated team of scientists and businesspeople that share a common mission: to improve access to medical care around the world by providing innovative diagnostic, epidemiological and clinical products.
Follow us on Facebook, LinkedIn, Twitter or at our website: www.sediabio.com
Ronald W. Mink, Ph.D., was appointed Chief Executive Officer. Dr. Mink was previously President and Chief Science Officer. He was reappointed President and will also serve as interim Chief Science Officer. Dr. Mink is a co-founder of Sedia. Roger Gale said "In his previous roles as President and Chief Science Officer, Dr. Mink made outstanding contributions to the growth and scale-up of Sedia's premier HIV products, while simultaneously leading research and development efforts toward novel product lines. His leadership skills, depth of scientific knowledge and passion for innovation will serve the Company well in his new role as Chief Executive Officer."
More on The Californer
- Swim Up Hill Consulting Secures New City Contracts, Expands National & Global Reach Ahead of LA28
- Fastest Growing Staffings Firms
- Inframark Continues to Build Its Community Management Capabilities and Multi-Disciplinary Presence in Arizona
- ICAST 2025: The Crystal-Clear Revolution Begins at Booth #3233
- Rachel Farris, CPA Featured on The AJ Brown Show to Discuss Act 60 Tax Incentives
Nancy Lime, previously Senior Vice President, Operations, was appointed Chief Operating Officer. Dr. Mink said "In her previous role as Senior Vice President, Operations, Ms. Lime has had a major impact on the performance of the Company. Over the past two years she has helped drive growth in production capacity, sales revenue and profitability and made a significant contribution to improvements in our quality systems. In 2020, she also led the design, build-out and relocation of the Company to our new assay development and manufacturing facility. Ms. Lime's experience, leadership and drive will serve the Company well in her new role as Chief Operating Officer."
Clay Roscoe, MD, MSc, previously Medical Advisor to the Company, was appointed Chief Medical Officer. Dr. Mink said "Dr. Roscoe brings to the Company years of clinical practice in HIV medicine and experience with the U.S. Centers for Disease Control (CDC) in Namibia, Southern Africa. Dr. Roscoe's field experience working first-hand with patients and leading national diagnostic assay programs for both HIV and TB will provide invaluable knowledge and insight for new product development and market analysis. We are pleased to welcome Dr. Roscoe to the team."
Jason Boone, Ph.D., was appointed President of Floragenex, a wholly owned subsidiary of Sedia. Dr. Boone will continue to serve as Sedia's Vice President of Sales and Marketing. Dr. Mink said "Dr. Boone began with Floragenex in 2009 and has continued to implement processes to facilitate growth for the Company. With a keen business acumen, scientific expertise, and enthusiasm in growing start-up companies, we are pleased to have Dr. Boone driving our Sales and Marketing program and serving in the role of President of Floragenex."
More on The Californer
- Brindle Pet Supplies Now Carries Badlands Ranch Dog Food in Canada
- Jade & Zelda Launch Virtually Human: A Groundbreaking Podcast Hosted by AI-Powered Virtual Humans
- Dr. Satyam Priyadarshy Joins Indemnify AI to Enrich AI Risk Financial Quantification
- $10 Million Allocated to Establish Crypto Treasury Focused on High Value Ethereum (ETH) & Bitcoin (BTC) as Long-Term Holdings for Cybersecurity Leader
- Fact: Trump lied — again. California gas prices remain lower than a week ago, month ago, and a year ago
About Sedia Biosciences Corporation
Sedia Biosciences is a privately held medical device and diagnostics company founded in 2009 and is based in Beaverton, Oregon, USA. Our goal is to become a leader in three areas intended to advance global access to care: (1) state-of-the-art rapid point-of-care diagnostic assays, (2) novel epidemiological disease surveillance assays and other Public Health tools and (3) innovative clinical specimen collection devices to improve and facilitate remote collection of specimens for follow-up testing. Sedia brings together a dedicated team of scientists and businesspeople that share a common mission: to improve access to medical care around the world by providing innovative diagnostic, epidemiological and clinical products.
Follow us on Facebook, LinkedIn, Twitter or at our website: www.sediabio.com
Source: Sedia Biosciences Corporation
0 Comments
Latest on The Californer
- 24/7 customizable AI answering service from Kell Web Solutions, Inc. helps businesses never miss a customer call, lead, or appointment again
- TikTok Star ArcadeFriends Attempts 24-Hour Claw Machine Marathon at Lucky Puppy Arcade in Las Vegas
- Revolutionary conversational AI transforms customer engagement with professional virtual receptionist answering service tailored for small busines
- New AI platform helps small businesses deliver always-available, professional customer service without added staff or complexity
- VoiceGenie AI empowers small businesses with 24/7, brand-driven customer engagement through an AI-powered virtual front desk receptionist
- California: Governor Newsom signs tribal-state gaming compact 7.14.25
- VoiceGenie AI empowers small businesses with human-like call answering and customer engagement—bridging the gap between automation and live
- New 24/7 AI solution transforms customer engagement and efficiency for small businesses seeking live virtual receptionist services
- Next-generation virtual receptionist service leverages AI to ensure every customer call and text is answered, enhancing efficiency and engagem
- Next-Gen AI Receptionist Elevates Customer Communication, Boosts Efficiency for Small Businesses
- California: Governor Newsom signs legislation 7.14.25
- New AI-Powered Platform from Kell Web Solutions Delivers 24/7 Professional, Automated Call Handling and Appointment Scheduling
- Kell Web Solutions Launches Next-Gen VoiceGenie AI Call Answering Service for Businesses
- 24/7 Conversational AI Platform Raises the Standard for Small Business Customer Engagement
- Pyro Marketing Launches New Website to Accelerate Growth for Fitness Brands
- QuickLogic Announces the Passing of Board Director Christine Russell
- KCON LA 2025, 106.3 RAIN FM 'Take Over' Special Event
- IEI USA Launches SHIELD Rugged Stainless Steel Panel PCs for Hygiene-Critical Industries
- In historic first, California powered by two-thirds clean energy – becoming largest economy in the world to achieve milestone
- North Island Credit Union Foundation Provides $5,000 in Teacher Grants To Benefit Educators & Students